1 Oct 2025
Naphthylisoquinoline alkaloids streamlining mycetoma drug discover by circumventing differential diagnosisPublisher sitePhytochemistry Letters, Actinomycetales infections and treatment
Active, last published 2026
In axial and atropisomeric chirality synthesis
Blaise Kimbadi
Lombe
Scholar“Research focused on Axial and Atropisomeric Chirality Synthesis and adjacent fields.”
Université de Kinshasa (UNIKIN)
DR Congo
Claim Your ProfileDR Congo10
H-index
421
Citations
Blaise has not officially claimed their profile. If you are Blaise, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
laise Kimbadi Lombe is a researcher working on Axial and Atropisomeric Chirality Synthesis. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Blaise's work has been cited 421 times across 4 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Axial and Atropisomeric Chirality Synthesis×9Molecular spectroscopy and chirality×5Carbohydrate Chemistry and Synthesis×4Analytical Chemistry and Chromatography×3Bioactive Compounds and Antitumor Agents×3
04 · Where I am
Affiliations
Affiliation on published researchUniversity of Würzburg, DR CongoDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
7 works11 Apr 2024Open access4cites
Naphthylisoquinoline alkaloids: novel agents against the causative pathogens of eumycetoma and actinomycetoma— <i>en route</i> to broad-spectrum antimycetomal drugsPublisher siteAntimicrobial Agents and Chemotherapy, Actinomycetales infections and treatment
1 Jan 2024Open access4cites
Droserone and dioncoquinone B, and related naphthoquinones as potent antiausterity agents against human PANC-1 pancreatic cancer cellsPublisher siteResults in Chemistry, Bioactive Compounds and Antitumor Agents
12 Apr 202110cites
Spirombandakamine A<sub>3</sub> and Cyclombandakamines A<sub>8</sub> and A<sub>9</sub>, Polycyclic Naphthylisoquinoline Dimers, with Antiprotozoal Activity, from a Congolese <i>Ancistrocladus</i> PlantPublisher siteJournal of Natural Products, Axial and Atropisomeric Chirality Synthesis
10 Oct 201872cites
Ancistrolikokine E<sub>3</sub>, a 5,8′-Coupled Naphthylisoquinoline Alkaloid, Eliminates the Tolerance of Cancer Cells to Nutrition Starvation by Inhibition of the Akt/mTOR/Autophagy Signaling PathwayPublisher siteJournal of Natural Products, Cancer Mechanisms and Therapy
27 Jul 201826cites
Ancistroyafungines A-D, 5,8′- and 5,1′-coupled naphthylisoquinoline alkaloids from a Congolese Ancistrocladus species, with antiausterity activities against human PANC-1 pancreatic cancer cellsPublisher siteFitoterapia, Axial and Atropisomeric Chirality Synthesis
1 Jan 2018Open access36cites
Michellamines A<sub>6</sub> and A<sub>7</sub>, and further mono- and dimeric naphthylisoquinoline alkaloids from a Congolese <i>Ancistrocladus</i> liana and their antiausterity activities against pancreatic cancer cellsPublisher siteRSC Advances, Axial and Atropisomeric Chirality Synthesis
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Blaise?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you